tiprankstipranks

Todd Brady Insider Profile

18 Followers
Todd Brady, President & CEO, Director at Aldeyra Therapeutics, holds 1.47M shares in Aldeyra Therapeutics (Ticker: ALDX), holds 153.29K shares in Oncobiologics Inc (Ticker: ONSIU), holds 0.00 shares in F-star Therapeutics (Ticker: FSTX).
tipranks
Todd Brady

Todd Brady
Aldeyra Therapeutics (ALDX)
President & CEO, Director

Ranked #5,334 out of 97,944 Corporate Insiders

Profitable Transactions

89%
8 out of 9 Profitable Transactions

Average Return

+30.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5M
99.96%
0.04%
0.00%
A breakdown of Todd Brady's holdings

Insider Roles

Aldeyra Therapeutics
(ALDX)
President & CEO, Director
Evoke Pharma
(EVOK)
Director
Outlook Therapeutics
(OTLK)
Director
Roles that Todd Brady holds in companies

Most Profitable Insider Trade

Stock:
Aldeyra Therapeutics
(ALDX)
Rating:Informative Buy
Date:Jun 27, 2022 - Jun 27, 2023
Return:+92.70%
The most profitable trade made by Todd Brady

Todd Brady's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Aldeyra Therapeutics
Mar 12, 2024
President & CEO, Director
Uninformative Sell
580.42K
$4.87M
ONSIU
Oncobiologics Inc
$723.52K
Outlook Therapeutics
Nov 14, 2016
Director
Uninformative Buy
117.39K
FSTX
F-star Therapeutics
Mar 09, 2023
Uninformative Sell
106.83K
$0.00
Evoke Pharma
Sep 24, 2014
Director
Informative Buy
22.80K
$2.12K
List of latest transactions for each holding click on a transaction to see Todd Brady's performance on stock

Todd Brady insider profile FAQ

What is the percentage of profitable transactions made by Todd Brady?
The percentage of profitable transactions made by Todd Brady is 89%.
    What is the average return per transaction made by Todd Brady?
    The average return per transaction made by Todd Brady is 30.00%.
      What stocks does Todd Brady hold?
      Todd Brady holds: ALDX, ONSIU, OTLK, FSTX, EVOK stocks.
        What was Todd Brady’s latest transaction?
        Todd Brady latest transaction was an Uninformative Sell of $580.42K.
          What was Todd Brady's most profitable transaction?
          Todd Brady’s most profitable transaction was an Informative Buy of ALDX stock on June 27, 2022. The return on the trade was 92.70%.
            What is Todd Brady's role in Aldeyra Therapeutics?
            Todd Brady's role in Aldeyra Therapeutics is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.